ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun ...

Detailed price information for Adia Nutrition Inc (ADIA) from The Globe and Mail including charting and trades.

The ASD market holds significant opportunities due to unmet needs for targeted treatments, given no approved therapies for core symptoms exist. With three late-stage developments and the expected ...

XTL will acquire 85% of NeuroNOS for consideration including 19.9% of XTL's issued share capital, $1 million in cash, and milestone-based contingent payments totaling up to $32.5 million. The ...

Find out how robot-assisted therapy for autism matches standard treatment outcomes while improving engagement and expanding ...

Astrogen Inc., a South Korean clinical-stage pharmaceutical company, said Wednesday it has signed a US$208.5 million deal ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...

The U.S. Food and Drug Administration is considering approval of the drug leucovorin to treat children with cerebral folate deficiency and symptoms of autism. Kevin Pelphrey is the Harrison-Wood ...

Drug addiction recovery looks different for everyone. Specific approaches for people on the autism spectrum may help more than traditional substance use disorder treatment. NINA MOINI: Those who have ...

InBloom Autism Services announced today the opening of 3 new state-of-the-art Learning Centers for children ages 18 months to 5 years old to receive Applied Behavior Analysis (ABA) therapy as a form ...

A new Iowa law now in effect will take away age and coverage limits for individuals covered by the state's insurance plan.